GW Pharmaceuticals PLC Director/PDMR Shareholding (2568Y)
May 13 2016 - 9:50AM
UK Regulatory
TIDMGWP
RNS Number : 2568Y
GW Pharmaceuticals PLC
13 May 2016
GW Pharmaceuticals PLC Director/PDMR Shareholding
13 May 2016
GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the
"Company")
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
Cambridge, UK, 13 May 2016: GW Pharmaceuticals (AIM: GWP,
NASDAQ:GWPH) hereby provides notification that the Company was
notified on 12 May 2016 of the following series of transactions in
the Ordinary 0.1 pence shares of GW Pharmaceuticals PLC.
On 12 May 2016 Dr Geoffrey Guy, a Director of the Company,
gifted 200,000 ordinary shares to each of two close family members.
Each gift represents less than 0.1% of shares in issue. The gifts
took place when the market price was 437 pence per share. As one of
these family members is a minor, 200,000 of the gifted shares
continue to be included within the calculation of Dr Guy's total
beneficial interest.
These transfers follow the sale, by the minor family member, of
300,000 Ordinary shares, representing 0.11% of shares in issue.
This sale of these shares completed on 11 May 2016, achieving an
average price of 444 pence per Ordinary share.
Following these transactions Dr Guy's total retained beneficial
interest in the Ordinary 0.1 pence shares of GW Pharmaceuticals plc
is 13,797,852 shares equating to 5.25% of shares in issue.
For further information, please contact:
GW Pharmaceuticals PLC +44 (0)1980 557 000
Adam George, Company Secretary
Peel Hunt LLP (Nominated Adviser)
James Steel/Oliver Jackson +44 (0) 20 7418 8900
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLLFSSETIVLIR
(END) Dow Jones Newswires
May 13, 2016 10:50 ET (14:50 GMT)
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024